Meet Medjeduse
The Meaning Behind Medjeduse
Our name, Medjeduse, merges "Medusa," known for inducing paralysis, with the Egyptian "Djed" (our logo), symbolizing spine stability and resurrection. This reflects our mission: transforming paralysis care through cutting-edge spinal cord repair technologies
Our Collaborative Research Environment
Our team collaborates with esteemed institutions for groundbreaking spinal cord research. Dr. Fatiha Nothias-Chahir leads the "Degeneration and Regeneration of Axons" team at the Institut de Biologie Paris-Seine, Sorbonne University.
We partner with experts from renowned parisian universities to drive advancements in spinal cord injury repair.
Meet two of our Co-Founders
Fatiha Nothias-Chahir, PhD
Awarded the 2023 Inventor Awards by Le Point, Fatiha Nothias-Chahir leads the "Axonal Regeneration and Growth" team at the Institut de Biologie Paris-Seine. With over 30 years at CNRS, she has focused on developing solutions to restore body functions after nervous system injuries, including a pioneering biomaterial for spinal cord repair.
Sylvia Soares, PhD
Recognized alongside Fatiha Nothias-Chahir in Le Point's 2023 Inventor Awards, Sylvia Soares is a professor at Sorbonne University and a key researcher in the "Axonal Regeneration and Growth" team. Her collaboration began during her thesis at the Alfred-Fessard Institute, leading to the co-development of an innovative biomaterial for spinal cord injury repair.
Leadership
CEO
Jean-Yves Nothias, PhD
Jean-Yves Nothias holds a PhD in molecular biology and has a background as a venture capitalist in the healthcare sector. He currently serves as the CEO of Medjeduse, leveraging his extensive experience to drive the company's mission in spinal cord injury treatment innovation.